You are here: Industry Insights > AstraZeneca

News List

Almost 100% of people have antibodies after second vaccine firstwordpharma
July 16, 2021
Imperial College London and Ipsos MORI have today published their latest antibody surveillance report showing, almost 100% of people tested positive for antibodies 14 days after their second dose of the Pfizer and AstraZeneca vaccine.
AZ scores final clearance for Alexion acquisition in the UK pharmatimes
July 15, 2021
AstraZeneca (AZ) is expecting its acquisition of Alexion Pharmaceuticals to close on 21 July after receiving final clearance from the UK Competition and Markets Authority (CMA).
PHE study finds COVID-19 vaccines ‘highly effective’ in at-risk groups pharmatimes
July 13, 2021
A new study from Public Health England (PHE) has found COVID-19 vaccine are as effective at preventing symptomatic disease in most people in clinical risk groups as the rest of the population.
FDA grants priority review to BLA for AstraZeneca-Amgen’s tezepelumab pharmaceutical-technology
July 09, 2021
The US Food and Drug Administration (FDA) has granted priority review to biologics license application (BLA) for AstraZeneca and Amgen’s experimental drug, tezepelumab, for asthma treatment.
Germany to donate all remaining AstraZeneca vaccines in Aug firstwordpharma
July 08, 2021
Germany will give all its remaining AstraZeneca COVID-19 vaccine doses to less developed countries in August, as reported This is Money on Wednesday.
AstraZeneca receives EC approval for $39bn Alexion acquisition pharmaceutical-technology
July 07, 2021
The European Commission has cleared the proposed acquisition by AstraZeneca of US-based biopharmaceutical company Alexion Pharmaceuticals for approximately $39bn or $175 a share.
First patients vaccinated with AstraZeneca’s COVID-19 variant vaccine europeanpharmaceuticalreview
July 05, 2021
The Phase II/III trial will assess the safety and immunogenicity of a AstraZeneca’s novel COVID-19 variant vaccine candidate, AZD2816.
Brazilian cities deny media reports that they used expired COVID-19 shots firstwordpharma
July 05, 2021
Municipalities across Brazil denied a newspaper report that said health ministry data showed cities administered at least 26,000 expired doses of AstraZeneca's COVID-19 vaccine, as reported in London South East.
AZ says MPO inhibitor AZD4831 shows promise in heart failure study pharmatimes
July 02, 2021
AstraZeneca (AZ) has revealed results from a mid-stage study of its investigational myeloperoxidase (MPO) inhibitor in patients with heart failure with preserved ejection fraction (HFpEF).
Extended dosing intervals may increase efficacy of Vaxzevria COVID-19 vaccine europeanpharmaceuticalreview
July 01, 2021
An analysis shows a single dose of Vaxzevria induced immunity lasting at least a year and an interval of up to 45 weeks significantly increases neutralising antibody titres.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page